Ad is loading...
UBX
Price
$1.16
Change
-$0.01 (-0.85%)
Updated
Nov 21 closing price
ZURA
Price
$2.90
Change
-$0.00 (-0.00%)
Updated
Nov 20 closing price
Ad is loading...

UBX vs ZURA

Header iconUBX vs ZURA Comparison
Open Charts UBX vs ZURABanner chart's image
Unity Biotechnology
Price$1.16
Change-$0.01 (-0.85%)
Volume$51.73K
CapitalizationN/A
Zura Bio
Price$2.90
Change-$0.00 (-0.00%)
Volume$476.47K
CapitalizationN/A
UBX vs ZURA Comparison Chart
Loading...
UBX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
ZURA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
UBX vs. ZURA commentary
Nov 22, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is UBX is a Sell and ZURA is a StrongBuy.

COMPARISON
Comparison
Nov 22, 2024
Stock price -- (UBX: $1.16 vs. ZURA: $2.93)
Brand notoriety: UBX and ZURA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: UBX: 76% vs. ZURA: 48%
Market capitalization -- UBX: $19.71M vs. ZURA: $189.35M
UBX [@Biotechnology] is valued at $19.71M. ZURA’s [@Biotechnology] market capitalization is $189.35M. The market cap for tickers in the [@Biotechnology] industry ranges from $463.61B to $0. The average market capitalization across the [@Biotechnology] industry is $2.63B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

UBX’s FA Score shows that 0 FA rating(s) are green whileZURA’s FA Score has 0 green FA rating(s).

  • UBX’s FA Score: 0 green, 5 red.
  • ZURA’s FA Score: 0 green, 5 red.
According to our system of comparison, ZURA is a better buy in the long-term than UBX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

UBX’s TA Score shows that 4 TA indicator(s) are bullish while ZURA’s TA Score has 4 bullish TA indicator(s).

  • UBX’s TA Score: 4 bullish, 4 bearish.
  • ZURA’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, UBX is a better buy in the short-term than ZURA.

Price Growth

UBX (@Biotechnology) experienced а -7.94% price change this week, while ZURA (@Biotechnology) price change was -18.61% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.74%. For the same industry, the average monthly price growth was -7.78%, and the average quarterly price growth was +1.53%.

Reported Earning Dates

UBX is expected to report earnings on May 09, 2023.

ZURA is expected to report earnings on Mar 28, 2023.

Industries' Descriptions

@Biotechnology (-3.74% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ZURA($189M) has a higher market cap than UBX($19.7M). ZURA YTD gains are higher at: -37.901 vs. UBX (-39.896). UBX has higher annual earnings (EBITDA): -20.99M vs. ZURA (-50.28M). ZURA has more cash in the bank: 188M vs. UBX (29M). UBX (0) and ZURA (0) have equivalent revenues.
UBXZURAUBX / ZURA
Capitalization19.7M189M10%
EBITDA-20.99M-50.28M42%
Gain YTD-39.896-37.901105%
P/E RatioN/A7.96-
Revenue00-
Total Cash29M188M15%
Total Debt20.7MN/A-
FUNDAMENTALS RATINGS
UBX: Fundamental Ratings
UBX
OUTLOOK RATING
1..100
56
VALUATION
overvalued / fair valued / undervalued
1..100
47
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
86
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
UBXZURA
RSI
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
72%
Bullish Trend 2 days ago
51%
Momentum
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 2 days ago
51%
MACD
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 2 days ago
44%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 2 days ago
59%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 2 days ago
63%
Advances
ODDS (%)
Bullish Trend 10 days ago
76%
Bullish Trend 11 days ago
81%
Declines
ODDS (%)
Bearish Trend 3 days ago
86%
Bearish Trend 2 days ago
80%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 2 days ago
59%
Aroon
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 2 days ago
61%
View a ticker or compare two or three
Ad is loading...
UBX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
ZURA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MAEGX14.020.04
+0.29%
BlackRock Unconstrained Equity Instl
ZVNBX38.370.08
+0.21%
Zevenbergen Growth Investor
AGAWX12.86N/A
N/A
Allspring Global Long/Short Equity R6
TISLX10.71N/A
N/A
Transamerica Intl Sust Eq R6
HILCX18.14-0.06
-0.33%
Hartford International Value C

UBX and

Correlation & Price change

A.I.dvisor indicates that over the last year, UBX has been loosely correlated with NCNA. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if UBX jumps, then NCNA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To UBX
1D Price
Change %
UBX100%
-0.85%
NCNA - UBX
42%
Loosely correlated
-0.78%
COGT - UBX
38%
Loosely correlated
-1.10%
ASMB - UBX
33%
Poorly correlated
-2.00%
ORMP - UBX
33%
Poorly correlated
+2.21%
MDGL - UBX
32%
Poorly correlated
+3.83%
More

ZURA and

Correlation & Price change

A.I.dvisor tells us that ZURA and DNA have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ZURA and DNA's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ZURA
1D Price
Change %
ZURA100%
-7.94%
DNA - ZURA
31%
Poorly correlated
-1.40%
UBX - ZURA
31%
Poorly correlated
+0.86%
NKTX - ZURA
30%
Poorly correlated
+0.81%
CGEM - ZURA
28%
Poorly correlated
-3.97%
BPMC - ZURA
27%
Poorly correlated
+0.22%
More